found that luteolin suppressed inflammation in DSS-induced colitis in vivo and promoted M2 polarization by activating the AMP-activated protein kinase (AMPK)/PPARγ pathway, reducing M1-associated cytokines (TNF-α, IL-6, and IL-1β) (14). Here, IL6 is linked to colitis.